HIV-1 has evolved multiple mechanisms to elude immune control. The view of virus as
classifiable into distinct subtypes needs to reflect the reality of the constant emergence of …

Combinations of antiretroviral drugs have proven remarkably effective in controlling the
progression of HIV disease and prolonging survival, but these benefits can be compromised …

When drug reactions resembling allergy occur, they are called drug hypersensitivity
reactions (DHR s) before showing the evidence of either drug‐specific antibodies or T cells …

This book grew out of a scientific review, originally published in Microbiological Reviews. It
has been updated and expanded-now citing more than 2100 references (100 pages of the …

Human immunodeficiency virus type 1 (HIV-1) is the causative agent of AIDS (10, 38, 105,
114). It is characterized by extensive and dynamic genetic diversity, generating variants …

Analysis of HIV drug resistance has identified sites on HIV target genes that convey
resistance to particular classes of agents. These data may be especially important in …

The purpose of this study was to document the genetic diversity of human immunodeficiency
virus type 1 (HIV-1) in the Democratic Republic of Congo (DRC; formerly Zaire). A total of …

There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs belonging to
three mechanistic classes: protease inhibitors, nucleoside and nucleotide reverse …

HIV-1 infection is characterized by genetic diversity wherein distinct viral subtypes (clades A,
B, C, D, E, F, G, K and O) are expanding in different geographical regions. This article deals …

HIV-1 comprises three groups, the main (M group), O (outlier) and N (non-M, non-O). The M
group, divided into 11 subtypes, is responsible for the global HIV-1 pandemic …